Cart summary

You have no items in your shopping cart.

Ifosfamide

SKU: orb1309923

Description

Ifosfamide is a nitrogen mustard prodrug analog of cyclophosphamide, activated by liver enzymes to alkylate DNA and form crosslinks, inhibiting strand separation and replication. It is widely used in cancer research, including in vitro cytotoxicity assays and in vivo xenograft studies for various solid tumors and lymphomas.

Research Area

Cell Biology, Molecular Biology

Images & Validation

−
Ifosfamide

Key Properties

−
CAS Number3778-73-2
MW261.09
Purity>99.99% (May vary between batches)
FormulaC7H15Cl2N2O2P
SMILESClCCNP1(=O)OCCCN1CCCl
TargetDNA/RNA Synthesis,DNA Alkylator/Crosslinker
SolubilityEthanol:49 mg/mL (187.67 mM);DMSO:250 mg/mL (957.52 mM);H2O:48 mg/mL (183.84 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.66 mM)

Bioactivity

−
In Vivo
In the liver, Ifosfamide it is a prodrug converted to active alkylated compounds by cytochrome P450 mixed function oxidase. Ifosfamide has shown promising antitumor effects in pediatric solid tumors, ovarian cancer, small cell lung cancer, non-Hodgkin's and Hodgkin's lymphomas.Ifosfamide (50 mM) increases the levels of CYP2C8/9, CYP3A4 proteins in hepatocytes, which in turn elevates the rate of 4-hydroxylation of the hepatocytes themselves. In hepatocytes with higher CYP3A4 expression than CYP3A5, Ifosfamide induced only CYP3A4 expression.Ifosfamide was highly cytotoxic to MCF-7 cells stably transfected with CYP2B1 (which could be significantly reduced by the CYP2B1 inhibitor, metipraminexone), but did not affect the expression of β-galactosidase and the pro-tumor cells of MCF- 7 cells. In the prevention of tumor recurrence, the combination of Ifosfamide and zoledronic acid was more effective than the drug alone in increasing bone formation and improving tissue repair.
Read more...
In Vitro
Ifosfamide induced bladder edema, which peaked 12 hours after Ifosfamide injection. Microscopic analysis showed vascular congestion, edema, hemorrhage, fibrin deposition, neutrophil infiltration and epithelial denudation. Inducible nitric oxide synthase immunoreactivity was strongly reactive in the cytoplasm of bladder epithelial cells, and diffuse necrosis was seen. Intraperitoneal administration of 100 mg/kg, 200 mg/kg and 400 mg/kg Ifosfamide to mice induced a dose-dependent increase in bladder wet weight and Evans blue extravasation. Pretreatment with mesna reduced the increase in bladder edema, whereas treatment with l - ng -nitroarginine methyl ester, antisera TNF-alpha or IL-1beta, thalidomide, or pentoxifylline inhibited bladder edema and microscopic changes. Antiserum treatment also inhibited the expression of inducible nitric oxide synthase within the uroepithelium. Nitric oxide produced by inducible nitric oxide synthase was involved in uroepithelial cell injury and in the inflammatory response leading to hemorrhagic cystitis after ifosfamide administration in mice.
Read more...

Storage & Handling

−
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
Crosslinker, DNA/RNA Synthesis, DNA Synthesis, DNASynthesis, DNAAlkylator, DNA Alkylator, DNA Alkylator/Crosslinker, Inhibitor, Ifosfamide, NSC109724, NSC-109724, NSC 109724, inhibit, Isophosphamide, RNASynthesis, RNA Synthesis

Similar Products

−
  • Sodium 2-mercaptoethanesulfonate

    Sodium 2-mercaptoethanesulfonate [orb1308684]

    99.93% (May vary between batches)

    19767-45-4

    164.18

    C2H5NaO3S2

    1 g
  • Palifosfamide-Tris

    Palifosfamide-Tris [orb1737980]

    1070409-31-2

    342.16

    C8H22Cl2N3O5P

    50 mg, 100 mg, 25 mg
  • Ifosfamide (Standard)

    Ifosfamide (Standard) [orb3025460]

    3778-73-2

    261.09

    C7H15Cl2N2O2P

    100 mg
  • Aldoifosfamide

    Aldoifosfamide [orb1986581]

    120144-70-9

    277.08

    C7H15Cl2N2O3P

    100 mg, 50 mg, 25 mg
  • L-Ifosfamide

    L-Ifosfamide [orb1702010]

    66849-34-1

    261.09

    C7H15Cl2N2O2P

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID
3690 ↗

Key Properties

−
No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Find More Protocols

Ifosfamide (orb1309923)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Login to review

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

50 mg
$ 80.00
1 ml x 10 mM (in DMSO)
$ 90.00
100 mg
$ 90.00
500 mg
$ 140.00
1 g
$ 180.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry
Need technical support? Find your Distributor Return and Tax Policy

Email

info@biorbyt.com

UK Office

+44 (0)1223 859353

US Office

+1 (415) 906-5211

CN Office

+86 (27)-87663101

Distributors

biorbyt.com/distributor